paclitaxel-covered balloon lutonix 035 dcb catheter (Lutonix Inc)
90
Structured Review
Lutonix Inc
paclitaxel-covered balloon lutonix 035 dcb catheter
Paclitaxel Covered Balloon Lutonix 035 Dcb Catheter, supplied by Lutonix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lutonix+035+dcb/paclitaxel+coated+dcb+lutonix/pm38809362-12-10-11
Average 90 stars, based on 1 article reviews
Paclitaxel Covered Balloon Lutonix 035 Dcb Catheter, supplied by Lutonix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lutonix+035+dcb/paclitaxel+coated+dcb+lutonix/pm38809362-12-10-11
Average 90 stars, based on 1 article reviews
paclitaxel-covered balloon lutonix 035 dcb catheter - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Editor's Choice - Drug Coated Balloon Angioplasty vs. Standard Percutaneous Transluminal Angioplasty in Below the Knee Peripheral Arterial Disease: A Systematic Review and Meta-Analysis. Article Snippet: Differences in duration of antiplatelet therapy and use of different types of DCBs. phenomenon for the IN.PACT DCB compared with Article Title: The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon. Article Snippet: The Global SFA Registry documents safety, effectiveness, and outcomes of the Article Title: The use of scoring balloons in the superficial femoral artery Article Snippet: Percutaneous transluminal angioplasty and stenting is becoming increasingly the first line treatment for patients with both claudication and critical limb ischaemia instead of surgery, with the aim of returning the patient's quality of life in the former and preventing amputation.. Drug eluting technologies have seen a large surge in popularity in recent years, and significant patient benefits have been seen with the use of drug eluting stents and balloons over the use of plain balloon angioplasty.. Unfortunately in many patients with arterial disease there is significant vessel wall calcification this can theoretically be a barrier to drug delivery, and can also be a contributing factor to flow limiting dissection and the subsequent need for bail out stenting. Article Title: The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon. Article Snippet: CONCLUSIONS The Global SFA Registry 24-month outcomes confirm the Lutonix 035 DCB is a safe and effective long-term treatment option in real-world patients with peripheral arterial disease with superficial femoral artery lesions, also in long lesions and Article Title: The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon. Article Snippet: Pre-dilatation before treating with the Article Title: The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon. Article Snippet: CONCLUSIONS The Global SFA Registry 24-month outcomes confirm the Medications:Article Title: The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease Article Snippet: Giannopoulos et al. , 2020 , Retrospective , DCB + LA vs. PTA + LA , Tosaka II or Tosaka III , Not available , DCB: InPact; LA: Turbo-PowerTM laser (Spectranetics Inc, Colorado Springs, CO, USA), Turbo-EliteTM (Spectranetics Inc) and Turbo-TandemTM (Spectranetics Inc) , [ ] . .. Thieme et al. , 2017 , Non randomized observational study , DCB , (1) Patients age 18 years or older; (2) Rutherford Classification category of <4; (3) stenotic or obstructive vascular lesions of the femoropopliteal arteries; (4) lesions treatable with available |